[61] demonstrated the CRISPR/Cas9 process could precisely target and cleave conserved areas in the HBV genome, resulting in sturdy suppression of viral gene expression and replication both of those in vitro and in vivo Furthermore, this process could inactivate the mutation of residual viral DNA. They concluded that CRISPR/Cas9 systems https://jaschab222yrj3.spintheblog.com/profile